U.S. Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals - SPY News | Rallies
U.S. Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals S SPY • 2026-09-23 Research actions reported by Reuters Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
Acadia Healthcare Company, Inc. (ACHC.O): Leerink Partners raises PT to $33 from $30
Allstate Corp (ALL.N): TD Cowen raises target price to $260 from $231
Ally Financial Inc (ALLY.N): Truist Securities cuts target price to $50 from $51
American Express Company (AXP.N): Truist Securities cuts target price to $370 from $375
Amgen Inc (AMGN.O): Jefferies raises target price to $410 from $367
Amneal pharma (AMRX.O): Oppenheimer initiates with outperform rating; price target $27
Amrize (AMRZ.N): Deutsche Bank cuts target price to $56 from $64
Anaptysbio, Inc. (ANAB.O): Leerink Partners cuts target price to $81 from $90
Anixa Biosciences Inc (ANIX.O): H.C. Wainwright cuts target price to $6 from $7
Ardent Health Inc (ARDT.N): BMO initiates with market perform rating; target price $11
Autozone, Inc. (AZO.N): BMO cuts target price to $3,500 from $4,000
Autozone, Inc. (AZO.N): D.A. Davidson cuts target price to $3,500 from $3,750
Autozone, Inc. (AZO.N): Exane BNP Paribas cuts target price to $3,561 from $3,979
Autozone, Inc. (AZO.N): Roth MKM cuts target price to $3,850 from $4,023
Autozone, Inc. (AZO.N): TD Cowen cuts target price to $3,400 from $3,500
Autozone, Inc. (AZO.N): Truist Securities cuts target price to $3,648 from $3,817
Bank7 Corp (BSVN.O): KBW raises target price to $62 from $56
Belden Inc. (BDC.N): Needham initiates coverage with buy rating; price target $140
Carnival Corp (CCL.N): Jefferies cuts target price to $33 from $35
CBIZ, Inc. (CBZ.N): William Blair cuts to market perform rating
Celldex Therapeutics Inc. (CLDX.O): Leerink Partners raises target price to $88 from $70
Citizens Financial (CFG.N): Truist Securities cuts target price to $77 from $80
Collegium Pharmaceutical (COLL.O): Oppenheimer initiates with outperform rating; PT $50
Community Health Systems (CYH.N): BMO initiates coverage with market perform rating; PT $3
Compass Therapeutics Inc. (CMPX.O): Guggenheim cuts target price to $4 from $8
Compass Therapeutics Inc. (CMPX.O): Jefferies cuts target price to $3 from $8
Compass Therapeutics Inc. (CMPX.O): Wedbush cuts target price to $1 from $5
Compass Therapeutics Inc. (CMPX.O): Wedbush cuts to neutral from outperform
Cormedix Inc. (CRMD.O): Oppenheimer initiates with outperform rating; price target $15
Cummins (CMI.N): JP Morgan cuts target price to $600 from $690
Dauch Corp (DCH.N): Jefferies cuts to hold from buy; cuts target price to $7.10 from $8.25
Fifth Third Bancorp (FITB.N): Truist Securities cuts target price to $63 from $64
Fox Corp (FOXA.O): Moffettnathanson raises target price by $5 to $70
Graphic Packaging Holding Company (GPK.N): JP Morgan cuts target price to $11.5 from $12.5
Graphic Packaging Holding Company (GPK.N): JP Morgan raises to overweight from neutral
Guardian Pharmacy Services Inc (GRDN.N): Keybanc initiates with overweight rating; PT $52
HCA Healthcare, Inc. (HCA.N): BMO initiates coverage with outperform rating; PT $495
Huntington Bancshares Inc (HBAN.O): Truist Securities cuts target price to $19 from $20
Innoviva, Inc. (INVA.O): Oppenheimer assumes coverage with outperform rating; target $35
KB Home (KBH.N): Barclays cuts target price to $49 from $57
KB Home (KBH.N): RBC cuts target price to $50 from $53
KB Home (KBH.N): Truist Securities cuts target price to $50 from $55
Keycorp (KEY.N): Truist Securities cuts target price to $23 from $24
M&T Bank Corporation (MTB.N): Truist Securities cuts target price to $250 from $268
Martin Marietta Materials, Inc. (MLM.N): Jefferies cuts target price to $670 from $720
Marvell Technology (MRVL.O): Seaport Research Partners initiates with buy rating; PT $270
Merck & Co Inc (MRK.N): TD Cowen raises target price to $155 from $137
Nektar Therapeutics (NKTR.O): Wedbush cuts target price to $50 from $80
Nike, Inc. (NKE.N): Oppenheimer cuts target price to $52 from $60
Onsemi (ON.O): Seaport Research Partners initiates coverage with buy rating; PT $100
Pacira Biosciences, Inc. (PCRX.O): Oppenheimer initiates with outperform rating; PT $32
Regions Financial (RF.N): Truist Securities cuts target price to $31 from $34
Roku, Inc. (ROKU.O): Moffettnathanson raises target price by $7 to $160
Semtech Corp (SMTC.O): Seaport Research Partners initiates with buy rating; target $200
SiTime Corp (SITM.O): Seaport Research Partners initiates coverage with neutral rating
Tenet Healthcare Corp (THC.N): BMO initiates with market perform rating; target price $265
the Baldwin Insurance Group (BWIN.O): Raymond James cuts to underperform from strong buy
the Toro Company (TTC.N): Oppenheimer initiates coverage with outperform rating; PT $120
Thor Industries, Inc. (THO.N): Jefferies cuts target price to $82 from $90
UiPath Inc (PATH.N): RBC cuts target price to $15 from $17
UiPath Inc (PATH.N): Truist Securities cuts target price to $14 from $17
Vanda Pharmaceuticals (VNDA.O): Oppenheimer initiates with outperform rating; PT $10
Vertex Pharmaceuticals Inc (VRTX.O): Jefferies raises target price to $640 from $633
Viatris Inc. (VTRS.O): Oppenheimer initiates with outperform rating; price target $25
Viking Therapeutics, Inc. (VKTX.O): Oppenheimer raises target price to $120 from $100
Viking Therapeutics, Inc. (VKTX.O): Truist Securities raises target price to $87 from $83
Vulcan Materials Co (VMC.N): Jefferies cuts target price to $320 from $345 Wall Street analysts revise targets on U.S. companies Sept. 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Allstate, Autozone and Vertex Pharmaceuticals, on Wednesday.
Highlights
Allstate Corp (ALL.N): TD Cowen raises target price to $260 from $231
Autozone, Inc. (AZO.N): D.A. Davidson cuts target price to $3,500 from $3,750
Martin Marietta Materials, Inc. (MLM.N): Jefferies cuts target price to $670 from $720
Vertex Pharmaceuticals Inc (VRTX.O): Jefferies raises target price to $640 from $633
Vulcan Materials Co (VMC.N): Jefferies cuts target price to $320 from $345
SPY•
